HIV Persists in Gut Tissue After Antiretroviral Use

Study suggests low likelihood of eradication efforts with currently available therapies

FRIDAY, Sept. 1 (HealthDay News) -- The human gut is a major reservoir for HIV and the virus stored there appears to be unaffected by highly active antiretroviral therapy (HAART), according to a report published in the September issue of the Journal of Acquired Immune Deficiency Syndromes.

Peter A. Anton, M.D., of the University of California Los Angeles, and colleagues studied 15 HIV-infected subjects who had been treated with HAART for an average of four years and had undetectable plasma HIV-1.

Although the researchers detected HIV-1 RNA in mucosal biopsy specimens from only 20 percent of the subjects, they detected mucosal HIV-1 DNA in 80 percent of the subjects and found no evidence for decay of the HIV-1 DNA in either gut-associated lymphoid tissue or peripheral blood mononuclear cells. They estimated that the total number of concurrent HIV-1 DNA-positive cells was 70,000 in peripheral blood mononuclear cells and 160,000 in gut-associated lymphoid tissue.

"Our findings indicate that -- despite prolonged treatment with HAART -- the detected long half-life estimates of HIV-1 DNA in gut-associated lymphoid tissue reflect those seen in peripheral blood mononuclear cells and lymph nodes and further support 'cryptic replication' and the low likelihood of eradication efforts with currently available therapies."

Abstract
Full Text (subscription or payment may be required)

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ